Gene Symbol | Gene ID | Gene Info |
---|---|---|
ID4
|
ENSG00000172201.6 | inhibitor of DNA binding 4, HLH protein |
TCF4
|
ENSG00000196628.9 | transcription factor 4 |
SNAI2
|
ENSG00000019549.4 | snail family transcriptional repressor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_19837611_19837907 | ID4 | 142 | 0.954913 | -0.90 | 9.0e-04 | Click! |
chr6_19836789_19836940 | ID4 | 753 | 0.687628 | -0.86 | 2.6e-03 | Click! |
chr6_19804205_19805055 | ID4 | 32987 | 0.196896 | -0.85 | 3.9e-03 | Click! |
chr6_19836946_19837146 | ID4 | 571 | 0.774614 | -0.84 | 4.4e-03 | Click! |
chr6_19838100_19838453 | ID4 | 659 | 0.598224 | -0.83 | 5.3e-03 | Click! |
chr8_49832237_49832502 | SNAI2 | 1619 | 0.544789 | -0.96 | 3.8e-05 | Click! |
chr8_49831086_49831370 | SNAI2 | 2760 | 0.413108 | -0.95 | 1.1e-04 | Click! |
chr8_49833115_49833392 | SNAI2 | 735 | 0.799179 | -0.94 | 2.0e-04 | Click! |
chr8_49831970_49832121 | SNAI2 | 1943 | 0.491853 | -0.93 | 2.2e-04 | Click! |
chr8_49831590_49831741 | SNAI2 | 2323 | 0.447812 | -0.89 | 1.4e-03 | Click! |
chr18_53214040_53214242 | TCF4 | 36141 | 0.176336 | -0.95 | 8.0e-05 | Click! |
chr18_53089837_53090372 | TCF4 | 361 | 0.893429 | -0.94 | 1.3e-04 | Click! |
chr18_52919735_52919886 | TCF4 | 23092 | 0.254151 | -0.94 | 2.0e-04 | Click! |
chr18_53526273_53526597 | TCF4 | 194417 | 0.028387 | -0.93 | 3.4e-04 | Click! |
chr18_53090404_53090609 | TCF4 | 763 | 0.698629 | -0.92 | 3.6e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_2083107_2083981 | 12.59 |
MOB3A |
MOB kinase activator 3A |
1847 |
0.21 |
chr16_50714281_50714981 | 7.51 |
SNX20 |
sorting nexin 20 |
592 |
0.64 |
chr19_6772910_6773160 | 7.50 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
66 |
0.96 |
chr2_113931617_113931842 | 7.08 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
155 |
0.91 |
chr19_17983159_17983879 | 7.07 |
SLC5A5 |
solute carrier family 5 (sodium/iodide cotransporter), member 5 |
737 |
0.53 |
chr11_1874347_1875032 | 6.87 |
LSP1 |
lymphocyte-specific protein 1 |
489 |
0.65 |
chr15_81591495_81592151 | 6.71 |
IL16 |
interleukin 16 |
66 |
0.98 |
chr8_134079225_134079805 | 6.63 |
SLA |
Src-like-adaptor |
6912 |
0.26 |
chr1_206731858_206732141 | 6.62 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
1506 |
0.37 |
chr1_161038546_161039545 | 6.44 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr17_62982296_62982856 | 6.22 |
AMZ2P1 |
archaelysin family metallopeptidase 2 pseudogene 1 |
12941 |
0.15 |
chr14_105527312_105527781 | 6.15 |
GPR132 |
G protein-coupled receptor 132 |
3727 |
0.23 |
chr22_37310592_37310811 | 6.13 |
CSF2RB |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
1026 |
0.44 |
chr22_37881738_37882044 | 6.04 |
MFNG |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
534 |
0.71 |
chr20_62270981_62271132 | 5.97 |
CTD-3184A7.4 |
|
12453 |
0.09 |
chr19_2290395_2291381 | 5.94 |
LINGO3 |
leucine rich repeat and Ig domain containing 3 |
1135 |
0.28 |
chr17_7239932_7240900 | 5.81 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
507 |
0.51 |
chr8_134086469_134086645 | 5.75 |
SLA |
Src-like-adaptor |
13954 |
0.23 |
chr7_106505707_106506635 | 5.67 |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
247 |
0.95 |
chr20_56195172_56195527 | 5.66 |
ZBP1 |
Z-DNA binding protein 1 |
101 |
0.98 |
chr12_58135257_58135844 | 5.54 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
390 |
0.63 |
chr22_17567910_17568443 | 5.40 |
IL17RA |
interleukin 17 receptor A |
2327 |
0.26 |
chr14_91866311_91866542 | 5.34 |
CCDC88C |
coiled-coil domain containing 88C |
17264 |
0.22 |
chr19_3785582_3786016 | 5.33 |
MATK |
megakaryocyte-associated tyrosine kinase |
215 |
0.88 |
chr11_414426_414987 | 5.32 |
SIGIRR |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
242 |
0.84 |
chr20_35273778_35274551 | 5.31 |
SLA2 |
Src-like-adaptor 2 |
120 |
0.95 |
chr17_73839317_73839828 | 5.23 |
UNC13D |
unc-13 homolog D (C. elegans) |
278 |
0.8 |
chr12_54891563_54891796 | 5.20 |
NCKAP1L |
NCK-associated protein 1-like |
184 |
0.93 |
chr22_37679801_37680063 | 5.09 |
CYTH4 |
cytohesin 4 |
1404 |
0.39 |
chr13_30510013_30510639 | 5.03 |
LINC00572 |
long intergenic non-protein coding RNA 572 |
9538 |
0.3 |
chr11_67174361_67174809 | 4.99 |
TBC1D10C |
TBC1 domain family, member 10C |
2925 |
0.09 |
chr2_202126146_202126672 | 4.93 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
270 |
0.92 |
chr19_14550010_14550416 | 4.87 |
PKN1 |
protein kinase N1 |
859 |
0.46 |
chr16_89042817_89042968 | 4.86 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
509 |
0.75 |
chr17_56414167_56414399 | 4.80 |
BZRAP1-AS1 |
BZRAP1 antisense RNA 1 |
281 |
0.76 |
chr14_105531964_105532391 | 4.78 |
GPR132 |
G protein-coupled receptor 132 |
395 |
0.85 |
chr22_50987475_50987644 | 4.76 |
KLHDC7B |
kelch domain containing 7B |
1097 |
0.24 |
chr16_29611589_29612053 | 4.62 |
ENSG00000266758 |
. |
1235 |
0.4 |
chr2_10472002_10472153 | 4.58 |
HPCAL1 |
hippocalcin-like 1 |
28251 |
0.15 |
chr14_100531999_100532513 | 4.55 |
EVL |
Enah/Vasp-like |
498 |
0.76 |
chr19_919882_920182 | 4.53 |
KISS1R |
KISS1 receptor |
2529 |
0.12 |
chr7_50351167_50351401 | 4.53 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
2966 |
0.38 |
chr12_117536177_117536841 | 4.50 |
TESC |
tescalcin |
742 |
0.76 |
chr10_46075820_46076565 | 4.48 |
MARCH8 |
membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase |
13747 |
0.25 |
chr9_95727201_95727619 | 4.37 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1167 |
0.54 |
chr4_42657844_42658977 | 4.35 |
ATP8A1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
700 |
0.59 |
chr16_21518478_21518933 | 4.35 |
ENSG00000265462 |
. |
1249 |
0.41 |
chrY_1604388_1604603 | 4.33 |
NA |
NA |
> 106 |
NA |
chr11_117858339_117858806 | 4.33 |
IL10RA |
interleukin 10 receptor, alpha |
1463 |
0.41 |
chr7_50344203_50344943 | 4.32 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
195 |
0.97 |
chr1_27668600_27669070 | 4.30 |
SYTL1 |
synaptotagmin-like 1 |
322 |
0.82 |
chrX_1654388_1654592 | 4.26 |
P2RY8 |
purinergic receptor P2Y, G-protein coupled, 8 |
1510 |
0.44 |
chr11_2468020_2468328 | 4.25 |
KCNQ1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
1953 |
0.26 |
chr7_104581843_104582295 | 4.24 |
ENSG00000251911 |
. |
29665 |
0.15 |
chr17_72755238_72755446 | 4.23 |
SLC9A3R1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
2800 |
0.14 |
chr14_93120741_93121126 | 4.21 |
RIN3 |
Ras and Rab interactor 3 |
2087 |
0.42 |
chr12_109026876_109027027 | 4.21 |
SELPLG |
selectin P ligand |
719 |
0.55 |
chr17_66233779_66233987 | 4.20 |
AMZ2 |
archaelysin family metallopeptidase 2 |
9832 |
0.16 |
chrX_51139039_51139450 | 4.16 |
RP11-348F1.3 |
|
70 |
0.98 |
chr1_40849833_40850457 | 4.12 |
SMAP2 |
small ArfGAP2 |
9825 |
0.18 |
chr5_175460576_175460928 | 4.11 |
THOC3 |
THO complex 3 |
931 |
0.5 |
chr17_3866518_3867344 | 4.10 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
654 |
0.71 |
chr2_8597006_8597252 | 4.10 |
AC011747.7 |
|
218767 |
0.02 |
chr14_53208430_53208600 | 4.06 |
STYX |
serine/threonine/tyrosine interacting protein |
11615 |
0.15 |
chr21_43483571_43483940 | 4.06 |
UMODL1 |
uromodulin-like 1 |
687 |
0.71 |
chr7_150264558_150265605 | 4.05 |
GIMAP4 |
GTPase, IMAP family member 4 |
557 |
0.78 |
chr1_198616268_198616512 | 4.03 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
8098 |
0.25 |
chr1_6525547_6525781 | 4.02 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
26 |
0.96 |
chr1_151129106_151129618 | 4.01 |
SCNM1 |
sodium channel modifier 1 |
222 |
0.51 |
chr19_6481304_6482171 | 3.99 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr3_13055439_13055590 | 3.99 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
26978 |
0.23 |
chr19_50003533_50003936 | 3.99 |
hsa-mir-150 |
hsa-mir-150 |
47 |
0.8 |
chr22_24824195_24824560 | 3.96 |
ADORA2A |
adenosine A2a receptor |
847 |
0.61 |
chr19_3180678_3181240 | 3.96 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
2223 |
0.2 |
chr7_50728203_50728447 | 3.94 |
GRB10 |
growth factor receptor-bound protein 10 |
33698 |
0.21 |
chr9_95728150_95728303 | 3.93 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1983 |
0.37 |
chr1_111418266_111418463 | 3.92 |
CD53 |
CD53 molecule |
2588 |
0.29 |
chr12_25204773_25204947 | 3.92 |
LRMP |
lymphoid-restricted membrane protein |
345 |
0.89 |
chr2_43360084_43360336 | 3.91 |
ENSG00000207087 |
. |
41578 |
0.18 |
chr19_16254302_16254453 | 3.90 |
HSH2D |
hematopoietic SH2 domain containing |
118 |
0.94 |
chr22_44391651_44392034 | 3.86 |
PARVB |
parvin, beta |
3249 |
0.27 |
chr21_34443264_34443646 | 3.86 |
AP000282.2 |
|
45 |
0.69 |
chr10_129846734_129847253 | 3.86 |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
1159 |
0.62 |
chr9_132650530_132650755 | 3.83 |
FNBP1 |
formin binding protein 1 |
30947 |
0.13 |
chr14_22539203_22539554 | 3.82 |
ENSG00000238634 |
. |
71509 |
0.12 |
chr1_209930383_209930698 | 3.79 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
1016 |
0.45 |
chr1_202129278_202129681 | 3.78 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
251 |
0.89 |
chr2_160761281_160761780 | 3.76 |
LY75-CD302 |
LY75-CD302 readthrough |
309 |
0.48 |
chr1_32314203_32314496 | 3.76 |
SPOCD1 |
SPOC domain containing 1 |
32697 |
0.13 |
chr1_204482636_204482787 | 3.75 |
MDM4 |
Mdm4 p53 binding protein homolog (mouse) |
2800 |
0.25 |
chr21_36600176_36600327 | 3.74 |
RUNX1 |
runt-related transcription factor 1 |
178610 |
0.03 |
chr19_55765328_55765511 | 3.73 |
PPP6R1 |
protein phosphatase 6, regulatory subunit 1 |
1718 |
0.17 |
chr3_183272411_183272703 | 3.72 |
KLHL6 |
kelch-like family member 6 |
920 |
0.55 |
chr20_56193926_56194226 | 3.71 |
ZBP1 |
Z-DNA binding protein 1 |
1374 |
0.49 |
chr2_241504790_241504976 | 3.67 |
RNPEPL1 |
arginyl aminopeptidase (aminopeptidase B)-like 1 |
338 |
0.81 |
chr1_2347262_2347748 | 3.67 |
PEX10 |
peroxisomal biogenesis factor 10 |
2269 |
0.17 |
chr15_81589438_81589936 | 3.66 |
IL16 |
interleukin 16 |
433 |
0.84 |
chr11_73692681_73692970 | 3.66 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
842 |
0.53 |
chr11_67173386_67173537 | 3.65 |
TBC1D10C |
TBC1 domain family, member 10C |
1801 |
0.14 |
chr1_2480724_2480985 | 3.65 |
TNFRSF14 |
tumor necrosis factor receptor superfamily, member 14 |
6224 |
0.1 |
chr7_45068352_45068655 | 3.64 |
CCM2 |
cerebral cavernous malformation 2 |
1232 |
0.4 |
chr8_66863582_66864279 | 3.63 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
69865 |
0.12 |
chr13_32608064_32608254 | 3.62 |
FRY-AS1 |
FRY antisense RNA 1 |
2383 |
0.3 |
chr12_15112961_15113206 | 3.62 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
1117 |
0.46 |
chr1_239883177_239883989 | 3.62 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
740 |
0.59 |
chr6_35265630_35266434 | 3.62 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
403 |
0.84 |
chr8_21769513_21769765 | 3.60 |
DOK2 |
docking protein 2, 56kDa |
1535 |
0.4 |
chr9_134145569_134145886 | 3.59 |
FAM78A |
family with sequence similarity 78, member A |
153 |
0.95 |
chr3_182834057_182834250 | 3.59 |
MCCC1 |
methylcrotonoyl-CoA carboxylase 1 (alpha) |
290 |
0.93 |
chr22_40299734_40299885 | 3.58 |
GRAP2 |
GRB2-related adaptor protein 2 |
2696 |
0.25 |
chr21_45560796_45560947 | 3.58 |
C21orf33 |
chromosome 21 open reading frame 33 |
4870 |
0.17 |
chr1_226920663_226921046 | 3.56 |
ITPKB |
inositol-trisphosphate 3-kinase B |
4305 |
0.27 |
chr16_88767682_88768006 | 3.56 |
RNF166 |
ring finger protein 166 |
833 |
0.34 |
chr17_4389201_4389708 | 3.55 |
RP13-580F15.2 |
|
194 |
0.92 |
chr10_15296464_15296906 | 3.53 |
RP11-25G10.2 |
|
17194 |
0.24 |
chr9_134147000_134147362 | 3.53 |
FAM78A |
family with sequence similarity 78, member A |
1271 |
0.44 |
chr4_6918537_6918793 | 3.52 |
TBC1D14 |
TBC1 domain family, member 14 |
6690 |
0.19 |
chr9_132646855_132647649 | 3.52 |
FNBP1 |
formin binding protein 1 |
34337 |
0.12 |
chr10_73533824_73534035 | 3.52 |
C10orf54 |
chromosome 10 open reading frame 54 |
674 |
0.7 |
chr4_154392532_154393036 | 3.51 |
KIAA0922 |
KIAA0922 |
5283 |
0.28 |
chr11_10477970_10478435 | 3.49 |
AMPD3 |
adenosine monophosphate deaminase 3 |
469 |
0.82 |
chr7_150434707_150435064 | 3.49 |
GIMAP5 |
GTPase, IMAP family member 5 |
449 |
0.8 |
chr13_78271067_78271525 | 3.49 |
SLAIN1 |
SLAIN motif family, member 1 |
727 |
0.51 |
chr10_43761610_43761802 | 3.47 |
RASGEF1A |
RasGEF domain family, member 1A |
661 |
0.77 |
chr3_107844575_107844939 | 3.45 |
CD47 |
CD47 molecule |
34885 |
0.22 |
chr9_95474388_95474658 | 3.45 |
IPPK |
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
41976 |
0.14 |
chr1_153330986_153331137 | 3.44 |
S100A9 |
S100 calcium binding protein A9 |
731 |
0.51 |
chr12_55378273_55378474 | 3.44 |
TESPA1 |
thymocyte expressed, positive selection associated 1 |
83 |
0.98 |
chr4_40198688_40199041 | 3.44 |
RHOH |
ras homolog family member H |
337 |
0.9 |
chr10_30994119_30994515 | 3.43 |
SVILP1 |
supervillin pseudogene 1 |
9467 |
0.26 |
chr21_46332173_46332515 | 3.42 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
969 |
0.4 |
chr22_37680309_37680627 | 3.40 |
CYTH4 |
cytohesin 4 |
1940 |
0.3 |
chr12_1613703_1614089 | 3.40 |
WNT5B |
wingless-type MMTV integration site family, member 5B |
25161 |
0.21 |
chr3_112217855_112218341 | 3.39 |
BTLA |
B and T lymphocyte associated |
107 |
0.98 |
chr5_95156034_95156185 | 3.38 |
GLRX |
glutaredoxin (thioltransferase) |
2306 |
0.24 |
chr3_71833648_71834232 | 3.36 |
PROK2 |
prokineticin 2 |
272 |
0.92 |
chr16_23848456_23848777 | 3.36 |
PRKCB |
protein kinase C, beta |
72 |
0.98 |
chr17_2699734_2700214 | 3.36 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
198 |
0.94 |
chr14_22969065_22969423 | 3.35 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
13073 |
0.1 |
chr9_134150778_134151758 | 3.35 |
FAM78A |
family with sequence similarity 78, member A |
666 |
0.69 |
chr3_18483093_18483271 | 3.34 |
SATB1 |
SATB homeobox 1 |
2917 |
0.27 |
chr4_1129896_1130047 | 3.34 |
RP11-20I20.2 |
|
3874 |
0.14 |
chr3_18485288_18486164 | 3.32 |
SATB1 |
SATB homeobox 1 |
639 |
0.52 |
chr20_57721382_57721625 | 3.31 |
ZNF831 |
zinc finger protein 831 |
44572 |
0.15 |
chr19_2289358_2289509 | 3.30 |
LINGO3 |
leucine rich repeat and Ig domain containing 3 |
2590 |
0.13 |
chr11_46367994_46368789 | 3.30 |
DGKZ |
diacylglycerol kinase, zeta |
565 |
0.7 |
chr6_41978137_41978501 | 3.30 |
ENSG00000206875 |
. |
7933 |
0.17 |
chr19_3178230_3178381 | 3.29 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
431 |
0.74 |
chr1_25254722_25254968 | 3.28 |
RUNX3 |
runt-related transcription factor 3 |
767 |
0.7 |
chr6_30459986_30460189 | 3.26 |
HLA-E |
major histocompatibility complex, class I, E |
2843 |
0.2 |
chr19_17516946_17517123 | 3.25 |
MVB12A |
multivesicular body subunit 12A |
80 |
0.86 |
chr17_38721330_38721617 | 3.24 |
CCR7 |
chemokine (C-C motif) receptor 7 |
238 |
0.92 |
chr11_314983_315695 | 3.22 |
IFITM1 |
interferon induced transmembrane protein 1 |
1486 |
0.17 |
chr5_176882439_176883305 | 3.22 |
DBN1 |
drebrin 1 |
6518 |
0.1 |
chr20_62709494_62709725 | 3.21 |
RGS19 |
regulator of G-protein signaling 19 |
1236 |
0.25 |
chr21_32554373_32554539 | 3.20 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
51917 |
0.17 |
chrX_1655540_1655863 | 3.19 |
P2RY8 |
purinergic receptor P2Y, G-protein coupled, 8 |
299 |
0.92 |
chr17_43302789_43303077 | 3.16 |
CTD-2020K17.1 |
|
3344 |
0.12 |
chr1_99336669_99336925 | 3.16 |
RP5-896L10.1 |
|
133035 |
0.05 |
chrY_1605531_1605856 | 3.15 |
NA |
NA |
> 106 |
NA |
chr6_53199988_53200168 | 3.15 |
ELOVL5 |
ELOVL fatty acid elongase 5 |
13509 |
0.2 |
chr20_57734824_57735045 | 3.15 |
ZNF831 |
zinc finger protein 831 |
31141 |
0.19 |
chr2_233925207_233925694 | 3.15 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
261 |
0.92 |
chr10_7513829_7514374 | 3.14 |
ENSG00000207453 |
. |
14670 |
0.24 |
chr13_24269864_24270160 | 3.13 |
AL139080.1 |
Uncharacterized protein |
52231 |
0.14 |
chr11_725898_726201 | 3.13 |
AP006621.9 |
|
998 |
0.31 |
chr15_101548752_101549003 | 3.13 |
RP11-505E24.3 |
|
40784 |
0.16 |
chr5_98362367_98362646 | 3.12 |
ENSG00000200351 |
. |
90055 |
0.09 |
chr7_50347932_50348149 | 3.12 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
277 |
0.95 |
chr1_111742376_111742661 | 3.12 |
DENND2D |
DENN/MADD domain containing 2D |
793 |
0.38 |
chr11_3880339_3880818 | 3.12 |
STIM1 |
stromal interaction molecule 1 |
3166 |
0.13 |
chr12_806266_806417 | 3.11 |
NINJ2 |
ninjurin 2 |
33396 |
0.14 |
chr17_75878240_75878391 | 3.11 |
FLJ45079 |
|
344 |
0.91 |
chr20_44633478_44633997 | 3.11 |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
3810 |
0.15 |
chr11_102188159_102188898 | 3.11 |
BIRC3 |
baculoviral IAP repeat containing 3 |
234 |
0.92 |
chr20_47439784_47439981 | 3.11 |
PREX1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
4538 |
0.31 |
chr8_21770420_21771232 | 3.10 |
DOK2 |
docking protein 2, 56kDa |
348 |
0.88 |
chr16_68319324_68319536 | 3.09 |
ENSG00000252026 |
. |
1209 |
0.25 |
chr4_57687218_57687847 | 3.09 |
SPINK2 |
serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor) |
328 |
0.85 |
chr19_18414950_18415223 | 3.09 |
LSM4 |
LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
11983 |
0.09 |
chrX_57313067_57313960 | 3.08 |
FAAH2 |
fatty acid amide hydrolase 2 |
374 |
0.92 |
chr1_2509263_2509520 | 3.08 |
RP3-395M20.9 |
|
3608 |
0.12 |
chr11_67171589_67172183 | 3.07 |
TBC1D10C |
TBC1 domain family, member 10C |
226 |
0.8 |
chr19_44282887_44283038 | 3.05 |
KCNN4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
2447 |
0.2 |
chr13_52396131_52396530 | 3.05 |
RP11-327P2.5 |
|
17897 |
0.18 |
chr7_106766845_106767175 | 3.05 |
CTA-360L10.1 |
|
7168 |
0.23 |
chr3_14474617_14474768 | 3.04 |
SLC6A6 |
solute carrier family 6 (neurotransmitter transporter), member 6 |
514 |
0.83 |
chr6_106969857_106970345 | 3.04 |
AIM1 |
absent in melanoma 1 |
10371 |
0.2 |
chr2_68967189_68967795 | 3.02 |
ARHGAP25 |
Rho GTPase activating protein 25 |
5478 |
0.28 |
chr5_74964815_74965486 | 3.02 |
ENSG00000207333 |
. |
40274 |
0.14 |
chr16_30196259_30196584 | 3.01 |
RP11-455F5.5 |
|
143 |
0.71 |
chr5_176784926_176785308 | 3.01 |
RGS14 |
regulator of G-protein signaling 14 |
279 |
0.82 |
chrX_1653880_1654070 | 3.00 |
P2RY8 |
purinergic receptor P2Y, G-protein coupled, 8 |
2025 |
0.36 |
chr2_37384636_37384824 | 3.00 |
EIF2AK2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
522 |
0.74 |
chr1_226921861_226922071 | 3.00 |
ITPKB |
inositol-trisphosphate 3-kinase B |
3193 |
0.3 |
chr5_16615946_16617123 | 3.00 |
RP11-260E18.1 |
|
499 |
0.54 |
chrY_1603880_1604065 | 2.99 |
NA |
NA |
> 106 |
NA |
chr3_49158467_49158728 | 2.98 |
USP19 |
ubiquitin specific peptidase 19 |
226 |
0.86 |
chr5_156693510_156694312 | 2.98 |
CTC-248O19.1 |
|
276 |
0.76 |
chr1_154317465_154317703 | 2.98 |
ENSG00000238365 |
. |
6365 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
3.3 | 13.2 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
3.1 | 9.2 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
3.0 | 8.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.9 | 8.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
2.8 | 14.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
2.7 | 10.8 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
2.6 | 5.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
2.6 | 15.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
2.6 | 2.6 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
2.5 | 7.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
2.5 | 7.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
2.5 | 2.5 | GO:0046645 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.3 | 6.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
2.1 | 17.1 | GO:0007172 | signal complex assembly(GO:0007172) |
2.1 | 8.4 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.1 | 6.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
2.1 | 6.2 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
2.0 | 2.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
1.9 | 5.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
1.8 | 5.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.6 | 4.8 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.6 | 15.9 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.6 | 4.7 | GO:0002507 | tolerance induction(GO:0002507) |
1.5 | 26.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
1.5 | 6.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
1.4 | 5.8 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.4 | 7.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.4 | 5.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
1.4 | 5.7 | GO:0015705 | iodide transport(GO:0015705) |
1.4 | 4.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
1.4 | 2.9 | GO:0033622 | integrin activation(GO:0033622) |
1.4 | 8.5 | GO:0050687 | negative regulation of response to biotic stimulus(GO:0002832) negative regulation of defense response to virus(GO:0050687) |
1.4 | 4.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
1.4 | 2.8 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
1.4 | 4.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.4 | 6.9 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
1.4 | 4.1 | GO:0015809 | arginine transport(GO:0015809) |
1.3 | 1.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.3 | 5.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.3 | 6.6 | GO:0043368 | positive T cell selection(GO:0043368) |
1.3 | 5.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.3 | 3.8 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
1.2 | 2.5 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
1.2 | 2.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.2 | 3.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.2 | 2.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.2 | 4.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.1 | 5.7 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
1.1 | 4.5 | GO:0001562 | response to protozoan(GO:0001562) |
1.1 | 2.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
1.1 | 3.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
1.1 | 3.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
1.1 | 8.9 | GO:0006491 | N-glycan processing(GO:0006491) |
1.1 | 8.7 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
1.1 | 3.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.1 | 4.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
1.1 | 2.2 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.1 | 1.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.1 | 2.1 | GO:0010107 | potassium ion import(GO:0010107) |
1.1 | 1.1 | GO:0019042 | viral latency(GO:0019042) |
1.0 | 5.2 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
1.0 | 20.9 | GO:0045576 | mast cell activation(GO:0045576) |
1.0 | 16.0 | GO:0045730 | respiratory burst(GO:0045730) |
1.0 | 3.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.0 | 2.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.0 | 4.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.0 | 1.9 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
1.0 | 3.8 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
1.0 | 43.2 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
1.0 | 2.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.0 | 5.7 | GO:0002467 | germinal center formation(GO:0002467) |
1.0 | 1.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.9 | 0.9 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.9 | 13.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 1.9 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.9 | 2.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.9 | 1.9 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.9 | 1.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.9 | 9.9 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.9 | 2.7 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.9 | 6.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.9 | 2.6 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.9 | 2.6 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.9 | 0.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.9 | 2.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.9 | 3.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.8 | 0.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.8 | 3.4 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.8 | 4.2 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.8 | 2.5 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.8 | 3.3 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.8 | 4.2 | GO:0006198 | cAMP catabolic process(GO:0006198) cyclic nucleotide catabolic process(GO:0009214) |
0.8 | 0.8 | GO:0001821 | histamine secretion(GO:0001821) |
0.8 | 1.7 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.8 | 12.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.8 | 2.5 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.8 | 0.8 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
0.8 | 8.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 4.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.8 | 1.6 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.8 | 3.2 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.8 | 8.1 | GO:0051322 | anaphase(GO:0051322) |
0.8 | 2.4 | GO:1902743 | regulation of lamellipodium assembly(GO:0010591) regulation of lamellipodium organization(GO:1902743) |
0.8 | 2.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.8 | 4.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.8 | 2.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 6.4 | GO:0034311 | diol metabolic process(GO:0034311) |
0.8 | 5.6 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.8 | 3.2 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.8 | 11.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.8 | 1.6 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.8 | 5.5 | GO:0036230 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.8 | 3.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.8 | 17.2 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.8 | 0.8 | GO:0060157 | urinary bladder development(GO:0060157) |
0.8 | 5.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.8 | 2.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.8 | 0.8 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.8 | 2.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.8 | 1.5 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.8 | 3.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.7 | 1.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.7 | 19.3 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.7 | 0.7 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.7 | 5.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.7 | 8.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.7 | 2.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.7 | 0.7 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.7 | 2.9 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.7 | 8.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.7 | 3.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 12.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.7 | 1.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.7 | 3.5 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.7 | 1.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 1.4 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.7 | 1.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.7 | 3.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.7 | 1.4 | GO:0045056 | transcytosis(GO:0045056) |
0.7 | 7.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.7 | 0.7 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.7 | 0.7 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.7 | 0.7 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.7 | 2.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.7 | 1.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.7 | 4.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.7 | 0.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.7 | 2.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.7 | 4.0 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.7 | 0.7 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.7 | 30.1 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.7 | 0.7 | GO:0002691 | regulation of cellular extravasation(GO:0002691) positive regulation of platelet activation(GO:0010572) |
0.7 | 1.3 | GO:0051138 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.7 | 2.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.7 | 2.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.7 | 3.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.7 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.6 | 1.3 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.6 | 1.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 2.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.6 | 2.6 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.6 | 3.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.6 | 5.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.6 | 1.3 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.6 | 0.6 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.6 | 1.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.6 | 4.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.6 | 2.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.6 | 1.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.6 | 4.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.6 | 1.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.6 | 2.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.6 | 1.8 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.6 | 6.5 | GO:0098926 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.6 | 1.2 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.6 | 1.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.6 | 3.5 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.6 | 4.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.6 | 0.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.6 | 1.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.6 | 0.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.6 | 1.7 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.6 | 5.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.6 | 1.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.6 | 1.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 2.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 1.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.6 | 1.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.6 | 21.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 1.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 1.7 | GO:0060179 | male mating behavior(GO:0060179) |
0.6 | 1.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.6 | 8.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.6 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 1.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.6 | 1.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.6 | 3.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.6 | 1.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.6 | 2.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.6 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.6 | 1.7 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.5 | 0.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.5 | 1.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.5 | 1.1 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.5 | 3.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 1.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 0.5 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.5 | 9.6 | GO:0007032 | endosome organization(GO:0007032) |
0.5 | 1.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 0.5 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.5 | 1.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.5 | 1.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.5 | 1.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 1.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.5 | 1.1 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.5 | 0.5 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.5 | 6.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.5 | 1.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.5 | 0.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.5 | 1.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.5 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.5 | 3.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.5 | 1.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.5 | 1.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.5 | 1.6 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.5 | 1.6 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.5 | 4.1 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.5 | 2.6 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 6.7 | GO:0043666 | regulation of phosphatase activity(GO:0010921) regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.5 | 2.1 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.5 | 2.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.5 | 2.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.5 | 9.7 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.5 | 2.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 0.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.5 | 2.5 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.5 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 2.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.5 | 1.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.5 | 1.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 2.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.5 | 0.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.5 | 3.5 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.5 | 1.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 20.5 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.5 | 0.5 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.5 | 1.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.5 | 0.5 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.5 | 10.9 | GO:0046847 | filopodium assembly(GO:0046847) |
0.5 | 2.5 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.5 | 0.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.5 | 0.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.5 | 2.9 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.5 | 1.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 3.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.5 | 1.0 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.5 | 2.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.5 | 4.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 1.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 0.5 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.5 | 2.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.5 | 1.0 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.5 | 1.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.5 | 7.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.5 | 6.7 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.5 | 2.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 2.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.5 | 1.4 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.5 | 1.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.5 | 0.5 | GO:0071436 | sodium ion export(GO:0071436) |
0.5 | 2.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 1.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.5 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.5 | 1.4 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.5 | 0.9 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.5 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 1.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.5 | 1.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 0.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 0.5 | GO:0043367 | CD4-positive, alpha-beta T cell differentiation(GO:0043367) |
0.5 | 1.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 3.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.5 | 1.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.5 | 2.3 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.5 | 0.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.5 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 2.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.4 | 3.6 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.4 | 1.8 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 0.9 | GO:1902622 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.4 | 1.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 0.4 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.4 | 1.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 0.9 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.4 | 1.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 4.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.4 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 1.8 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.4 | 0.9 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 3.9 | GO:0000303 | response to superoxide(GO:0000303) |
0.4 | 4.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.4 | 2.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.4 | 2.6 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.4 | 4.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.4 | 1.7 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.4 | 1.3 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.4 | 1.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.4 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 0.9 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.4 | 1.7 | GO:0001510 | RNA methylation(GO:0001510) |
0.4 | 0.9 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.4 | 0.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 3.4 | GO:0033363 | secretory granule organization(GO:0033363) |
0.4 | 1.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.4 | 4.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.4 | 3.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.4 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 4.6 | GO:0006906 | vesicle fusion(GO:0006906) |
0.4 | 0.8 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.4 | 2.5 | GO:0098543 | detection of other organism(GO:0098543) |
0.4 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 1.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 1.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.4 | 0.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.4 | 0.4 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.4 | 3.3 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.4 | 0.4 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.4 | 7.3 | GO:0006997 | nucleus organization(GO:0006997) |
0.4 | 1.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.4 | 3.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.4 | 2.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 0.4 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.4 | 4.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 2.0 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 0.8 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.4 | 2.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.4 | 1.6 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.4 | 28.2 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.4 | 0.8 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 1.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.4 | 0.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.4 | 1.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.4 | 27.9 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.4 | 0.8 | GO:0009405 | pathogenesis(GO:0009405) |
0.4 | 0.8 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.4 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 1.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 1.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 1.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 1.9 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.4 | 1.2 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.4 | 3.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.4 | 9.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.4 | 1.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 5.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 28.8 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.4 | 3.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 1.1 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.4 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.4 | 0.7 | GO:0003160 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) |
0.4 | 1.5 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.4 | 1.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 0.4 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.4 | 0.4 | GO:0046794 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.4 | 1.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.4 | 0.4 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.4 | 1.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 0.4 | GO:0006168 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.4 | 0.7 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.4 | 0.4 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.4 | 1.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.4 | 1.1 | GO:0006303 | non-recombinational repair(GO:0000726) double-strand break repair via nonhomologous end joining(GO:0006303) |
0.4 | 1.4 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.4 | 1.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 1.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.4 | 1.4 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 1.1 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.4 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 1.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.4 | 7.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.3 | 5.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.3 | 0.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.3 | 0.3 | GO:2000279 | negative regulation of telomerase activity(GO:0051974) negative regulation of DNA biosynthetic process(GO:2000279) |
0.3 | 0.7 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.3 | 3.1 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 1.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.3 | 1.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 1.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 1.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 1.4 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.3 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 2.0 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.3 | 0.3 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.7 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 0.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 1.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 2.7 | GO:0006900 | membrane budding(GO:0006900) |
0.3 | 1.3 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.3 | 1.0 | GO:1902750 | mitotic G2 DNA damage checkpoint(GO:0007095) negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) mitotic G2/M transition checkpoint(GO:0044818) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 0.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 1.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 1.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 1.0 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.3 | 0.7 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.3 | 1.6 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 15.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.3 | 0.7 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.3 | 1.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 1.0 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.3 | 0.6 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 4.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 23.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 0.3 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.3 | 1.6 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 0.3 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.3 | 5.4 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.3 | 1.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 2.9 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 0.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.3 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.3 | 0.9 | GO:0045006 | DNA deamination(GO:0045006) |
0.3 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
0.3 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 0.6 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.3 | 0.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 4.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.3 | 2.8 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 1.2 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.3 | 0.6 | GO:0016265 | obsolete death(GO:0016265) |
0.3 | 0.3 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.3 | 65.0 | GO:0016568 | chromatin modification(GO:0016568) |
0.3 | 0.6 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.3 | 6.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 0.3 | GO:0016233 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 0.9 | GO:0032200 | telomere organization(GO:0032200) |
0.3 | 2.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 0.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 4.3 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.3 | 0.6 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.3 | 105.9 | GO:0006955 | immune response(GO:0006955) |
0.3 | 2.7 | GO:0048937 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.3 | 3.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 4.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.3 | 0.6 | GO:0001881 | receptor recycling(GO:0001881) |
0.3 | 5.7 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.3 | 1.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.3 | 2.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.3 | 0.6 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.3 | 0.9 | GO:2001235 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.3 | 0.6 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.3 | 0.6 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.3 | 1.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 0.3 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.3 | 1.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 0.3 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.3 | 3.2 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.3 | 1.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 1.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.3 | 0.9 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.9 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 4.9 | GO:0072659 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.3 | 6.9 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.3 | 2.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 1.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 1.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 0.9 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.3 | 0.6 | GO:0070265 | necrotic cell death(GO:0070265) |
0.3 | 0.6 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.3 | 9.9 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 2.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 3.1 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.3 | 3.4 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.3 | 2.5 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 0.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 7.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.8 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 1.4 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 1.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.6 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.3 | 0.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.3 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.3 | 0.3 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.3 | 0.8 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.3 | 0.8 | GO:0021779 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.3 | 4.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.3 | 1.9 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.3 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 2.4 | GO:0009268 | response to pH(GO:0009268) |
0.3 | 0.8 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.3 | 1.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 2.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 0.8 | GO:0043276 | anoikis(GO:0043276) |
0.3 | 3.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.8 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.3 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 2.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.3 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 0.8 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.3 | 0.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 0.3 | GO:0072193 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.3 | 0.5 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.3 | 0.8 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 4.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.3 | 7.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.3 | 3.4 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.3 | 2.6 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.3 | 1.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 1.0 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.3 | 1.8 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
0.3 | 1.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 0.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.3 | 1.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 1.0 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.3 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 3.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 1.8 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.3 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 3.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.3 | 27.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.3 | 0.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.3 | 2.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 1.0 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 2.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 0.7 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 0.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.5 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.2 | 2.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.5 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.2 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.7 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.2 | 1.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 1.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 37.8 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.2 | 0.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 1.9 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.2 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 2.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.9 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 1.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.2 | 0.5 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.2 | 2.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.7 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.9 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.2 | 0.9 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.2 | 0.2 | GO:1901722 | positive regulation of metanephros development(GO:0072216) regulation of cell proliferation involved in kidney development(GO:1901722) |
0.2 | 9.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 3.2 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 5.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.2 | 1.8 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.2 | 0.7 | GO:0097035 | phospholipid scrambling(GO:0017121) regulation of membrane lipid distribution(GO:0097035) |
0.2 | 1.4 | GO:0009451 | RNA modification(GO:0009451) |
0.2 | 0.2 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 1.6 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.2 | 2.9 | GO:1903363 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) negative regulation of cellular protein catabolic process(GO:1903363) |
0.2 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 0.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 6.5 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.2 | 0.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 3.5 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 24.6 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.2 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.4 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.7 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.2 | 0.7 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.6 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 2.8 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.2 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 1.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.2 | 2.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 0.2 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.2 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.2 | 1.0 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.8 | GO:0001906 | cell killing(GO:0001906) |
0.2 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 3.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 1.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 0.6 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.2 | 1.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 9.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.2 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.2 | 1.0 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.2 | 0.4 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.2 | 0.6 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.4 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.2 | 0.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 0.4 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.2 | 14.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 0.8 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 2.4 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.2 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 4.4 | GO:0000910 | cytokinesis(GO:0000910) |
0.2 | 0.8 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.2 | 3.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 5.2 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 1.2 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 4.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 1.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 5.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 0.2 | GO:1904063 | negative regulation of cation transmembrane transport(GO:1904063) |
0.2 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.6 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.2 | 0.4 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.2 | 1.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 7.2 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.2 | 3.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 1.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.9 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.2 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.2 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.2 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.2 | 0.4 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.2 | 16.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.2 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 2.4 | GO:0030317 | sperm motility(GO:0030317) |
0.2 | 0.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 2.9 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 0.2 | GO:0051088 | monocyte activation(GO:0042117) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.4 | GO:0000239 | pachytene(GO:0000239) |
0.2 | 0.5 | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) |
0.2 | 0.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.2 | 13.5 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.2 | 12.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 15.1 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 1.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 2.3 | GO:0046649 | lymphocyte activation(GO:0046649) |
0.2 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 0.9 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.2 | 3.7 | GO:0006914 | autophagy(GO:0006914) |
0.2 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.9 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.2 | 1.2 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 0.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 3.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.2 | 1.5 | GO:0051297 | centrosome organization(GO:0051297) |
0.2 | 0.7 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 2.6 | GO:1903825 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.2 | 1.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.2 | 1.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.2 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.2 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.2 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.2 | GO:0065005 | plasma lipoprotein particle assembly(GO:0034377) protein-lipid complex assembly(GO:0065005) |
0.2 | 2.7 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.2 | 0.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 2.0 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.2 | 0.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 1.4 | GO:0043414 | macromolecule methylation(GO:0043414) |
0.2 | 0.2 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.2 | 0.8 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 0.3 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.2 | 0.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 29.3 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.3 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.6 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.1 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.4 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.3 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 3.8 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.1 | 0.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.8 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 2.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.6 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 1.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 5.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 2.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.9 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.7 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.4 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 1.4 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.4 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 1.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 11.2 | GO:0006281 | DNA repair(GO:0006281) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 5.5 | GO:0009161 | ribonucleoside monophosphate metabolic process(GO:0009161) |
0.1 | 0.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 1.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 1.3 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 1.2 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 5.4 | GO:0070085 | glycosylation(GO:0070085) |
0.1 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 1.5 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 2.6 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.5 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.8 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.1 | 0.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.1 | 0.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.2 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.3 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.5 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 1.8 | GO:0009749 | response to glucose(GO:0009749) |
0.1 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.6 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.1 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.4 | GO:0042116 | macrophage activation(GO:0042116) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.3 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.3 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 0.9 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 1.8 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.1 | GO:0032722 | positive regulation of chemokine production(GO:0032722) |
0.1 | 0.6 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 0.1 | GO:1901990 | regulation of cell cycle phase transition(GO:1901987) regulation of mitotic cell cycle phase transition(GO:1901990) |
0.1 | 1.7 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.1 | 0.1 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.1 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 5.2 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.1 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.2 | GO:0006833 | water transport(GO:0006833) |
0.1 | 0.3 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.1 | GO:0009123 | nucleoside monophosphate metabolic process(GO:0009123) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.1 | 0.3 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 5.7 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.0 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 1.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.1 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.0 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 2.0 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.0 | 0.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 1.0 | GO:0044839 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.1 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.0 | GO:0051445 | regulation of meiotic nuclear division(GO:0040020) regulation of meiotic cell cycle(GO:0051445) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.8 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.1 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.3 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.0 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 0.1 | GO:0032438 | melanosome organization(GO:0032438) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.2 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.0 | GO:0030832 | regulation of actin filament length(GO:0030832) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.0 | GO:0002274 | myeloid leukocyte activation(GO:0002274) |
0.0 | 0.2 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 4.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 18.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
2.4 | 9.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
2.3 | 7.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.2 | 2.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.9 | 21.2 | GO:0001772 | immunological synapse(GO:0001772) |
1.6 | 11.0 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
1.5 | 4.6 | GO:0042629 | mast cell granule(GO:0042629) |
1.5 | 4.5 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 2.9 | GO:0044462 | external encapsulating structure part(GO:0044462) |
1.5 | 2.9 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.4 | 5.7 | GO:0070820 | tertiary granule(GO:0070820) |
1.3 | 1.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.3 | 18.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.3 | 11.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.1 | 4.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.1 | 7.6 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.1 | 7.6 | GO:0001891 | phagocytic cup(GO:0001891) |
1.1 | 9.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.1 | 3.2 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
1.1 | 3.2 | GO:0032009 | early phagosome(GO:0032009) |
1.0 | 5.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) |
1.0 | 6.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.0 | 3.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.0 | 4.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.9 | 7.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.9 | 6.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.8 | 2.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.8 | 6.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.8 | 3.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 3.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.7 | 2.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.7 | 3.5 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 4.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.7 | 4.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.7 | 4.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 4.7 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 8.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.7 | 2.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.7 | 3.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 5.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.7 | 2.6 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.6 | 3.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.6 | 1.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 3.8 | GO:0000791 | euchromatin(GO:0000791) |
0.6 | 7.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.6 | 1.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.6 | 4.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.6 | 1.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 2.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 1.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.6 | 2.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 2.2 | GO:0030120 | vesicle coat(GO:0030120) |
0.6 | 6.1 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 0.5 | GO:0044309 | neuron spine(GO:0044309) |
0.5 | 2.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.5 | 3.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 4.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.5 | 3.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.5 | 1.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 17.2 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.5 | 1.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 23.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.5 | 27.8 | GO:0016605 | PML body(GO:0016605) |
0.5 | 1.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 5.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.5 | 1.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.5 | 1.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.5 | 1.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 1.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 2.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 5.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 4.2 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.5 | 1.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.5 | 1.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.5 | 1.9 | GO:0005902 | microvillus(GO:0005902) |
0.5 | 0.9 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.5 | 2.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.5 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.5 | 1.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.5 | 1.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 1.8 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.4 | 0.9 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.4 | 4.4 | GO:0005768 | endosome(GO:0005768) |
0.4 | 3.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 7.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.4 | 6.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 1.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 1.3 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.4 | 4.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 14.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 1.3 | GO:0000800 | lateral element(GO:0000800) |
0.4 | 1.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.4 | 6.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.4 | 1.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 11.9 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 4.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.4 | 1.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 2.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 2.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 2.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.4 | 1.5 | GO:0033011 | perinuclear theca(GO:0033011) |
0.4 | 7.9 | GO:0042611 | MHC protein complex(GO:0042611) |
0.4 | 3.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 7.1 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 7.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.4 | 7.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 1.8 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.4 | 4.4 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 15.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.4 | 18.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.4 | 1.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 2.1 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 3.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.3 | 3.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 2.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 2.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 36.2 | GO:0005769 | early endosome(GO:0005769) |
0.3 | 1.0 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 1.4 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.0 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.3 | 3.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 3.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 3.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 0.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.3 | 6.5 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 2.0 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 1.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 1.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 2.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 2.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 3.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 0.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 18.2 | GO:0044440 | endosomal part(GO:0044440) |
0.3 | 3.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 5.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 0.3 | GO:0000803 | sex chromosome(GO:0000803) |
0.3 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 0.3 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 2.2 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 0.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 2.1 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 1.8 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.3 | 2.1 | GO:1902555 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) endoribonuclease complex(GO:1902555) |
0.3 | 0.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 12.3 | GO:0005770 | late endosome(GO:0005770) |
0.3 | 1.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 0.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.3 | 1.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 15.7 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 0.6 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.3 | 27.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 16.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.3 | 0.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 1.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 4.5 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 4.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 7.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.3 | 1.1 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 2.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 9.1 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.3 | 1.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 0.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 1.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 3.5 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 52.2 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.3 | 19.6 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 4.5 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.3 | 1.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 1.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 9.2 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.3 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 0.8 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 0.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.3 | 2.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 20.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 3.5 | GO:0005844 | polysome(GO:0005844) |
0.2 | 9.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 1.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 6.3 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 4.1 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 2.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 20.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 15.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 3.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 13.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 1.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 3.1 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.9 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.2 | 2.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 6.2 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 3.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 2.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 334.6 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 1.4 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.9 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.2 | 1.5 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.2 | 1.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.2 | 1.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 2.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 3.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 0.8 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.2 | 14.2 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 4.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 9.9 | GO:0005840 | ribosome(GO:0005840) |
0.2 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 1.1 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.5 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 1.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.2 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 1.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 25.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.2 | 0.9 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.2 | 0.5 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.7 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 5.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 0.2 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.2 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.2 | 0.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.3 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 3.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 12.3 | GO:0098552 | side of membrane(GO:0098552) |
0.2 | 100.3 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 5.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 0.6 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 0.3 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.7 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 8.3 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 5.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 54.4 | GO:0042175 | endoplasmic reticulum membrane(GO:0005789) nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 3.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.6 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 2.0 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 24.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.3 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.1 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 1.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 50.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 1.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 5.4 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.6 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.1 | 5.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 13.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 3.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.1 | GO:0036379 | myofilament(GO:0036379) |
0.1 | 3.4 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 150.7 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.2 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 1.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 4.6 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 113.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.3 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.0 | 33.5 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
3.0 | 14.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
3.0 | 8.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.4 | 7.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
2.3 | 9.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.3 | 6.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.2 | 13.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
2.2 | 6.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.1 | 6.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
2.1 | 6.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.0 | 5.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.9 | 5.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.8 | 5.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.6 | 4.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.6 | 15.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.5 | 18.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.5 | 8.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.4 | 8.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.4 | 23.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.4 | 4.1 | GO:0004875 | complement receptor activity(GO:0004875) |
1.4 | 11.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.4 | 4.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.3 | 7.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.2 | 3.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.2 | 7.4 | GO:0051400 | BH domain binding(GO:0051400) |
1.2 | 3.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.2 | 8.5 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
1.2 | 9.7 | GO:0050700 | CARD domain binding(GO:0050700) |
1.2 | 3.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
1.2 | 3.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.2 | 4.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.2 | 3.6 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
1.2 | 8.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.2 | 9.4 | GO:0005522 | profilin binding(GO:0005522) |
1.1 | 4.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.1 | 9.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.1 | 5.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.1 | 6.4 | GO:0005521 | lamin binding(GO:0005521) |
1.1 | 2.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.0 | 3.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 3.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.0 | 3.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.0 | 6.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
1.0 | 12.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
1.0 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) protein phosphorylated amino acid binding(GO:0045309) |
1.0 | 3.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.9 | 3.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.9 | 5.6 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.9 | 3.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.9 | 2.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.9 | 44.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.9 | 17.2 | GO:0043621 | protein self-association(GO:0043621) |
0.9 | 2.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 18.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.9 | 1.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.9 | 14.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 2.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.9 | 3.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.9 | 4.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.9 | 0.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.9 | 3.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.9 | 2.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.8 | 3.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.8 | 10.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.8 | 3.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.8 | 2.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.8 | 5.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.8 | 2.4 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.8 | 2.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 7.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.8 | 3.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.8 | 0.8 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.8 | 3.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.8 | 3.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.8 | 3.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.8 | 5.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.8 | 1.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.8 | 28.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.8 | 6.8 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.7 | 2.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.7 | 2.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.7 | 13.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.7 | 2.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.7 | 2.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 2.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 5.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.7 | 0.7 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.7 | 4.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.7 | 2.9 | GO:0005534 | galactose binding(GO:0005534) |
0.7 | 2.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.7 | 3.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.7 | 2.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.7 | 6.2 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 18.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.7 | 3.4 | GO:0071814 | low-density lipoprotein particle binding(GO:0030169) lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.7 | 2.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.7 | 6.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.7 | 3.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.7 | 2.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.7 | 3.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.7 | 1.3 | GO:0045569 | TRAIL binding(GO:0045569) |
0.7 | 3.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 2.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.6 | 0.6 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.6 | 9.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 2.6 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 2.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 0.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.6 | 7.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 2.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.6 | 1.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.6 | 2.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 3.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 1.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.6 | 5.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.6 | 2.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 4.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 10.2 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.6 | 4.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.6 | 2.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.6 | 17.5 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 1.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.6 | 4.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.6 | 2.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.6 | 2.2 | GO:0004340 | glucokinase activity(GO:0004340) |
0.6 | 1.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.6 | 1.7 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.5 | 3.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 1.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 1.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 1.6 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 5.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.5 | 2.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 1.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.5 | 2.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 1.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.5 | 2.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.5 | 1.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 0.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.5 | 2.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.5 | 2.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 3.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 1.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 3.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.5 | 3.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 5.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 2.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 2.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.5 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 2.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 2.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.5 | 1.5 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.5 | 2.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 1.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.5 | 2.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 2.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 2.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.5 | 3.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 7.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 1.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 1.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 3.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 1.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 6.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 2.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.5 | 0.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 0.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.5 | 1.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.5 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.5 | 27.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.5 | 6.5 | GO:0010181 | FMN binding(GO:0010181) |
0.5 | 6.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 1.4 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 4.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 2.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 2.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 5.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.5 | 1.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 1.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 2.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 3.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 5.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 4.8 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.4 | 1.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 5.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.4 | 2.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 12.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 0.4 | GO:0005035 | death receptor activity(GO:0005035) |
0.4 | 1.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 10.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 1.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 2.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 2.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.4 | 1.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.4 | 1.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 21.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.4 | 2.5 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.4 | 12.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 4.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 1.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.4 | 4.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.4 | 8.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 1.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.4 | 2.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.4 | 1.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 10.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.4 | 3.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.4 | 1.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.4 | 4.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 1.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 0.4 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 47.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.4 | 2.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 2.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 3.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.2 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 1.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.4 | 2.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.4 | 0.8 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.4 | 4.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.4 | 1.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.4 | 1.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 4.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.4 | 1.9 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.4 | 4.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.4 | 1.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 1.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 2.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.4 | 0.4 | GO:0004396 | hexokinase activity(GO:0004396) |
0.4 | 7.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.4 | 5.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.4 | 8.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.4 | 0.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.4 | 0.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 0.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.4 | 1.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.4 | 1.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.4 | 2.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.4 | 1.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 1.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 1.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 5.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.3 | 1.7 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 1.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 7.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.3 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 3.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 2.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.3 | 1.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 1.7 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.3 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 0.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.0 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.3 | 3.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.3 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.3 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 2.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 2.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 2.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.3 | 0.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.3 | 1.6 | GO:0070403 | NAD+ binding(GO:0070403) |
0.3 | 1.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 1.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 4.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 1.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 3.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 0.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 1.2 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.3 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 2.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 1.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.3 | 1.8 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.3 | 1.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 2.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 9.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.3 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.3 | 10.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.3 | 0.9 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.3 | 0.6 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.3 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 1.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 0.9 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 2.4 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 0.9 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.3 | 2.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 0.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 2.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 2.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 12.2 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 0.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 3.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 3.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 1.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 21.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 1.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.3 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 2.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 0.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 1.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 4.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 15.5 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.3 | 1.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.3 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 9.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 3.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 53.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 9.4 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.3 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.8 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 2.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 1.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.3 | 7.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 4.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 5.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 1.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 7.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.3 | 5.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.3 | 2.4 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.3 | 3.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.3 | 2.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 1.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.3 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 1.3 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 0.5 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 5.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.3 | 5.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 0.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 2.5 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.2 | 0.7 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 5.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 1.7 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 2.9 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.7 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.2 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 5.3 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.2 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 3.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 5.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 6.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 1.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 1.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 8.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.7 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 0.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 2.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 1.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.2 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.2 | 1.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.2 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.6 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.2 | 0.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 1.9 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 3.4 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
0.2 | 0.8 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 3.8 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.2 | 0.6 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.2 | 1.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 1.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 0.6 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.2 | 1.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 22.4 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.2 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.8 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 2.6 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.2 | 4.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 6.0 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.2 | 1.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 29.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.2 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 56.5 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 1.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 2.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.2 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 2.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 6.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.4 | GO:0035173 | histone kinase activity(GO:0035173) |
0.2 | 0.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.2 | 1.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 1.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 1.8 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.2 | 0.7 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 3.9 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.0 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 7.0 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 4.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.5 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 1.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.2 | 4.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.7 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 2.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 1.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 1.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.5 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 0.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 2.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 2.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.2 | 0.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 2.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 1.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 1.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 12.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 1.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 2.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 13.6 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.6 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.4 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 3.0 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 1.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 2.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.9 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 4.4 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.6 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 22.7 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 2.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 1.9 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 2.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 38.3 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 5.7 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 1.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 2.7 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.1 | 1.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 1.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 1.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.6 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.3 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 4.9 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.3 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.3 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.1 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 2.0 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.9 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 112.7 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 2.6 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.1 | 0.2 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.1 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 1.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 1.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.9 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 0.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.3 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 2.2 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 2.2 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 2.6 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 5.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0015278 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.3 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 8.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) lipase inhibitor activity(GO:0055102) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 21.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.0 | 132.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.7 | 18.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.7 | 24.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.6 | 17.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.5 | 4.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.4 | 9.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.3 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.3 | 7.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.3 | 23.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.2 | 34.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.1 | 1.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
1.0 | 7.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.9 | 33.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.9 | 30.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.9 | 9.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.9 | 15.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.8 | 6.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.8 | 1.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 15.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.8 | 6.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 1.6 | PID MYC PATHWAY | C-MYC pathway |
0.8 | 9.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.7 | 10.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 13.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 1.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.7 | 5.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.7 | 2.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 2.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.7 | 9.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.6 | 6.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 8.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 12.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.6 | 3.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 10.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.6 | 3.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 17.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.6 | 15.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.6 | 4.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.6 | 3.3 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 5.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 16.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 11.1 | PID FOXO PATHWAY | FoxO family signaling |
0.5 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 7.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 1.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 13.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.4 | 4.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 3.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 3.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 4.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 5.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 3.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 5.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 10.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 7.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 9.1 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 6.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 4.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 3.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 3.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 8.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.3 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 7.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 2.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 3.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 2.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 9.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 6.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 6.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 2.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 2.7 | PID ATM PATHWAY | ATM pathway |
0.2 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 5.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 11.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 2.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 2.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 10.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 7.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 4.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 3.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 1.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 2.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 3.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 4.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 4.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 3.2 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 3.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.6 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 6.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.0 | 24.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.0 | 6.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.0 | 25.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.0 | 25.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.8 | 26.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.7 | 12.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.7 | 1.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.4 | 32.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.3 | 21.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.2 | 19.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.1 | 2.3 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
1.1 | 6.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.0 | 2.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.0 | 3.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.0 | 11.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.0 | 14.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.0 | 10.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.0 | 18.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.0 | 13.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.9 | 40.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.9 | 3.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 47.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 13.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.9 | 13.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.8 | 11.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.8 | 8.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.8 | 3.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.8 | 19.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.8 | 12.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.7 | 5.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.7 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 3.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.7 | 12.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 2.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 8.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 3.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.6 | 8.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 9.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.6 | 7.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 21.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 15.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.6 | 17.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 8.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.6 | 22.9 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.6 | 0.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.6 | 3.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 10.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 9.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 2.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 11.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 9.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 6.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.5 | 31.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 1.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 20.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.4 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 6.7 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.4 | 1.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 12.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 2.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 3.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.4 | 7.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 3.0 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 1.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 3.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 7.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 13.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 0.8 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.4 | 2.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.4 | 5.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 3.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 8.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.4 | 21.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 2.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 5.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 4.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 3.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 5.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 2.7 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.3 | 17.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 6.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 2.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 9.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 2.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 1.0 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.3 | 3.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 18.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 3.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 6.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 1.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 3.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.3 | 3.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 10.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 8.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 6.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 3.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 10.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 3.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 2.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 8.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.3 | 0.6 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.3 | 3.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 3.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 7.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 4.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 15.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 4.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.3 | 2.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 0.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 1.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 7.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 5.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.3 | 1.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 4.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 2.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 6.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 1.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 3.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 0.5 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 0.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 5.9 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 5.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 7.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 2.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 1.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.2 | 2.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 2.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 0.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 6.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 3.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.2 | 1.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 7.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 3.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 4.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 5.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 17.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 15.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 3.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 3.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 0.6 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.2 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 0.6 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.2 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 3.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 8.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 10.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 4.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 2.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 4.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 2.8 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 2.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 0.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 0.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 20.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 8.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.2 | 2.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 2.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 2.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 2.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 2.4 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 4.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 8.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.2 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 5.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 3.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.6 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 3.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 2.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.3 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 1.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 2.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 2.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.5 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 2.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 1.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 4.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 6.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |